Free Trial
Ed Ridley-Day

Ed Ridley-Day Analyst Performance

Managing Director at Rothschild & Co Redburn

Ed Ridley-Day is a stock analyst at Rothschild & Co Redburn in the healthcare sector, covering 6 publicly traded companies. Over the past year, Ed Ridley-Day has issued 3 stock ratings, including buy and hold recommendations. While full access to Ed Ridley-Day's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ed Ridley-Day's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 10 Years
Buy Recommendations
42.86% 3 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy42.9%3 ratings
Hold57.1%4 ratings
Sell0.0%0 ratings

Out of 7 total stock ratings issued by Ed Ridley-Day at Rothschild & Co Redburn, the majority (57.1%) have been Hold recommendations, followed by 42.9% Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
83.3% of companies on NYSE
5 companies
NASDAQ
16.7% of companies on NASDAQ
1 company

Ed Ridley-Day, an analyst at Rothschild & Co Redburn, currently covers 6 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
6 companies
100.0%

Ed Ridley-Day of Rothschild & Co Redburn specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
4 companies
66.7%
LIFE SCIENCES TOOLS & SERVICES
2 companies
33.3%

Ed Ridley-Day's Ratings History at Rothschild & Co Redburn

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Abbott Laboratories stock logo
ABT
Abbott Laboratories
10/2/2026Upgrade$96.62$127.00Buy
Medline stock logo
MDLN
Medline
1/12/2026Set Price Target$40.52$42.00
Medline stock logo
MDLN
Medline
1/12/2026Initiated Coverage$40.52$42.00Neutral
Danaher Corporation stock logo
DHR
Danaher
10/8/2025Reiterated Rating$208.63$220.00Neutral
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
9/18/2025Set Price Target$100.06$130.00
Stryker Corporation stock logo
SYK
Stryker
9/18/2025Initiated Coverage$376.60$420.00Neutral
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
9/18/2025Initiated Coverage$99.84$130.00Buy
Qiagen N.V. stock logo
QGEN
Qiagen
4/4/2025Downgrade$40.40Neutral